These findings indicate that G6PD impacts CD8+ T cell activation, immune cell infiltration, and PD‐L1 expression via the mTOR pathway, thereby facilitating immune evasion in HCC. The gene discussed is CD8A; the disease is hepatocellular carcinoma.